Searchable abstracts of presentations at key conferences in endocrinology

ea0032p966 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

A retrospective-prospective study of the effect of octreotide LAR in acromegalic patients

Pemovska Gordana , Volkanovska Ance , Jovanoska Biljana , Shubeska-Stratrova Slaviva

Objective: Surgery is considered first-line treatment for pituitary GH secreting macroadenoma. Since surgical removal of the pituitary tumor is subtotal, medical treatment has become the mainstay of acromegaly. The aim of our study was to assess the effect of octreotide LAR (OCT-LAR) therapy in patients with acromegaly.Patients and methods: Ten acromegalic patients were treated with OCT-LAR 20 mg/28 days. The effect was evaluated after 12 months of treat...